Bethanechol
Back to searchMolecule Structure
Scientific Name
Bethanechol
Description of the Drug
Bethanechol is a muscarinic agonist used to treat postoperative and postpartum nonobstructive functional urinary retention and neurogenic atony of the bladder with retention.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01019
http://www.drugbank.ca/drugs/DB01019
Brand Name(s)
Not Available
Company Owner(s)
Sun Pharmaceutical Industries Inc, Watson Laboratories Inc, Ascot Hosp Pharmaceuticals Inc Div Travenol Laboratories Inc, Amneal Pharmaceutical, Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa, Impax Laboratories Inc, Able Laboratories Inc, Upsher Smith Laboratories Llc, Lannett Holdings Inc, Glenwood Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Muscarinic acetylcholine receptor M2 | SINGLE PROTEIN | AGONIST | CHEMBL211 |
Muscarinic acetylcholine receptor M3 | SINGLE PROTEIN | AGONIST | CHEMBL245 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL37096 | ||
PharmGKB | PA448613 | ||
Human Metabolome Database | HMDB0015154 | ||
DrugBank | DB01019 | ||
PubChem | 2370 | ||
Mcule | MCULE-4959115853 | ||
LINCS | LSM-5196 | ||
Nikkaji | J7.089K | ||
BindingDB | 39342 | ||
EPA CompTox Dashboard | DTXSID5048398 | ||
DrugCentral | 358 | ||
Guide to Pharmacology | 297 | ||
rxnorm | URECHOLINE | BETHANECHOL CHLORIDE | BETHANECHOL |
KEGG Ligand | C06850 | ||
ChEBI | 3084 |